MDMA Board of Directors (Photos & Bios)
 CHAIRMANJOE E. KIANI Chairman & CEO Masimo Corporation Joe E. Kiani is the founder, CEO and Chairman of the Board of Masimo Corporation. Mr. Kiani has held these positions since Masimo’s inception in 1989. Mr. Kiani is an inventor on more than 50 patents related to signal processing, sensors, and patient monitoring, including patents for the invention of motion and low-perfusion tolerant pulse oximetry. Prior to founding Masimo Corporation, Mr. Kiani served as regional technical manager for Anthem Electronics, and field applications engineer for Bell Industries, which distributed advanced semiconductor components. He serves on the Board of SABA, a publicly traded software company focused on Human Capital Development and Management solutions, Orange County Section of March of Dimes, and the Medical Device Manufacturers Association (MDMA). Mr. Kiani has a B.S.E.E. degree and an M.S.E.E. degree from San Diego State University. |
 VICE CHAIRMANEAMONN P. HOBBS President & CEO AngioDynamics, Inc. Eamonn Hobbs is President and Chief Executive Officer of AngioDynamics; he is also a co-founder of the company. Mr. Hobbs has more than 25 years experience in interventional radiology, interventional cardiology and the gastroenterology medical device industry. He is a bio-medical engineer, with a Bachelor of Sciences in Plastics Engineering with a Biomaterials emphasis from University of Massachusetts, Lowell. Mr. Hobbs started his career at Cook Incorporated. From 1983 to 1985, he was President and CEO, and Chairman of the Board of Hobbs Medical Inc., a medical device firm focused on interventional devices for gastroenterologists. He later served as a Vice President and Senior Vice-President of E-Z-EM, with operational responsibility for what would become AngioDynamics. Mr. Hobbs is also a member of the Board of Directors for the Society of Interventional Radiology Foundation. In 2005 he was granted an Honorary Fellowship from by the Society of Interventional Radiology and is the only member of the medical device industry to serve on the SIR strategic planning committee. He joined the Medical Device Manufacturers Association Board in 2005. |
TREASURERALEXIS LUKIANOV Chairman and CEO NuVasive, Inc. Mr. Lukianov serves as Chairman and CEO of NuVasive, a medical device spine company which develops and markets unique minimally disruptive surgery products. Since joining NuVasive as CEO in 1999, he has led the company through venture capital financing, commercialization, initial public offering, public follow-on offering and a convertible debt financing for potential acquisitions. NuVasive has a market capitalization of well over $1 billion. Lukianov has over 25 years of senior management experience in the orthopedic industry and has been associated with building highly-successful companies. He was a founder, chairman and chief executive officer of BackCare Group, which he sold to a Robert Bass company. Lukianov served as a director of the Ilizarov Business Unit of Smith & Nephew Orthopaedics, and was directly responsible for bringing revolutionary limb lengthening and tissue regeneration technology out of Russia and establishing worldwide manufacturing, marketing, and sales. He was also a key manager in a sports medicine joint venture in artificial ligaments between Stryker Corporation and Meadox Medicals. Mr. Lukianov serves on several industry trade boards of California Health Institute (CHI), BIOCOM, and Medical Device Manufacturers Association as well as Volcano Corp., and Opthonix. |
 SECRETARYKELVYN H. CULLIMORE, JR. President & CEO Dynatronics Corporation Kelvyn Cullimore Jr presently serves as Chairman, President & CEO of Dynatronics Corporation, a publicly traded medical device manufacturer with headquarters in Cottonwood Heights, Utah. Kelvyn has served as a Director and Officer of Dynatronics since it was founded in 1979. Prominent in the physical therapy market, Dynatronics is known for its advanced technology electrotherapy and ultrasound devices, pain management systems and aesthetic products. Dynatronics equipment is used by top therapists and trainers with a majority of professional sports franchises and college teams owning Dynatronics products. In November 2004 he was elected the first Mayor of Cottonwood Heights, Utah, a new city of approximately 40,000 residents after serving for three years on the committee to incorporate the area. Since 1992, Kelvyn has been a member of the Board and chairman of the audit committee of ITEC Attractions, an entertainment company operating in Branson, Missouri. In 2003 he joined the board of directors of the Medical Device Manufacturers Association headquartered in Washington, D.C. and currently serves on its executive committee. Kelvyn also serves as a member of the Life Sciences Advisory Board for the Utah Technology Council. |
 IMMEDIATE PAST CHAIRMANNANCY M. BRIEFS President & CEO Eleme Medical, Inc. Ms. Briefs is the President and CEO of Elemé Medical Inc., a premier, venture backed aesthetics company focused on the body shaping. Elemé Medical is a Delaware corporation with headquarters in Merrimack, New Hampshire. SmoothShapes® system with Photomology® is Elemé Medical’s preeminent product to launch. Designed to improve the appearance of cellulite, and perfected after seven years of development, SmoothShapes effectively improves the appearance of cellulite and is a non-invasive method for producing longer lasting results. Thermal and non-destructive, Photomology’s unique mechanism of action combines dynamic laser and light energy with mechanical massage and vacuum. Ms. Briefs’ background includes 25 years in the medical device industry building shareholder value by developing and commercializing innovative paradigm shifting technologies in cardiovascular medicine and aesthetics. Ms. Briefs currently serves on the following boards, Elemé Medical Inc., Medical Device Manufacturers Association, National Judge EOY Entrepreneur of the Year Awards Life Sciences. She is listed as an inventor on four issued and five pending U.S. Patents and holds an MBA in Finance & Marketing from Golden Gate University along with a BS in Business Administration and a BA in Psychology from Emporia State University, Kansas. |
WAYNE K. BARLOW Wayne K. Barlow is an inventor/entrepreneur and business leader. He has been the President and Chief Executive Officer of Wescor, Inc, since the company was founded in 1970. He invented or co-invented many of the unique instruments and products that have made Wescor a respected name in the diagnostic laboratory market and the world leader in the laboratory diagnosis of cystic fibrosis. Mr. Barlow is a past MDMA chairman and also served as chairman of the Utah Biomedical Industry Council and president of the National Medical Device Coalition. He was a charter member of the FDA/Industry Grassroots Initiatives Task Force when it was formed in 1995 and has served as its chairman since 1998. He received the “Commissioner’s Special Citation” for his work in developing a “cooperative/collaborative working relationship between the medical device industry and the FDA.” Mr. Barlow earned A.S. and B.S. degrees in Electrical Engineering, minoring in physics. He is a former member of the Engineering Research Faculty at Utah State University and is a member and a past chairman of the Industry Advisory Council of the Department of Computer and Electrical Engineering. Among numerous other honors, he received the “Professional Achievement Award” from the USU Alumni Association and the College of Business, the “Outstanding Alumnus Award” from the Department of Computer and Electrical Engineering, College of Engineering, and was named “Industry Executive of the Year” in a readership poll conducted in 1993 by Medical Device Executive magazine. Mr. Barlow was the 2008 Regional Winner in the Ernst & Young “Entrepreneur of the Year” Program. |
 WIL BORENPresident, Biomet International Biomet, Inc. Mr. Boren serves as the President of Biomet International, Biomet Inc. Biomet and its subsidiaries design, manufacture and market products used primarily by musculoskeletal medical specialist in both surgical and non-surgical therapy. The Company's product portfolio encompasses reconstructive devices, including orthopedic joint replacement devices, bone cements and accessories, autologous therapies and dental reconstructive implants; fixation products, including electrical bone growth stimulators, internal and external orthopedic fixation devices, craniomaxillofacial implants and bone substitute materials; spinal products, including spinal stimulation devices, spinal hardware and orthobiologics; and other products, such as arthroscopy products and softgoods and bracing products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in more than 100 countries. Mr. Boren started with Biomet in 1999, and has held various sales, marketing, and management positions in Biomet Sports Medicine, Biologics, and Contract Sales. In August of 2007 Mr. Boren was appointed to his current position of President of Biomet International. Mr. Boren is a graduate of Indiana University, a member of the Healthcare Financial Management Association, and holds various board positions in his town of Warsaw, Indiana. |
 CHRISTOPHER G. CHAVEZPresident & CEO Advanced Neuromodulation Systems, Inc. Christopher Chavez is president of Advanced Neuromodulation Systems (ANS) (www.ans-medical.com), a division of St. Jude Medical. Joining ANS as president, CEO and director in 1998, Mr. Chavez guided ANS through a nine-year period of successful growth and through its acquisition by St. Jude Medical. Mr. Chavez started his career in the medical device industry with Johnson & Johnson Medical, Inc. in 1981 and progressed through several cross-functional roles to become vice president and general manager of the infection control business unit, with approximately $500 million in worldwide revenues. Prior to ANS, he served as vice president of worldwide marketing and strategic planning at Eastman Kodak’s health imaging division, where the division’s five worldwide business units reported to him. He holds an MBA from Harvard University and currently serves as a board member for the Medical Device Manufacturers Association and Advanced Medical Optics. |
 RYAN D. DRANTGeneral Partner New Enterprise Associates Ryan joined NEA in 1996, and became a General Partner in 2004. He specializes in healthcare investments in the specialty pharma, medical device and healthcare information technology sectors. Present board memberships include BENU, Carticept Medical, Concentric Medical, ExploraMed III, ForHealth Technologies, Intrinsic Therapeutics, Neotract, PatientKeeper, Simplex Diabetic Supply, Spine Wave, Viacor and Vibrynt. Ryan also co-manages NEA's investment in TriVascular2. Past board memberships include ESP Pharma (acquired by Protein Design Labs, Inc.), Esprit Pharma (acquired by Allergan), FoxHollow Technologies (NASDAQ: FOXH), Provation Medical (acquired by Wolters Kluwer), and Proxima Therapeutics (acquired by Cytyc Corporation), and Ryan co-led NEA’s investment in Xcel Pharmaceuticals (acquired by Valeant Pharmaceuticals, Inc.). Prior to joining NEA, Ryan was with the Health Care Investment Banking Group of Alex. Brown & Sons in San Francisco. Previously, he worked in the San Francisco office of Arthur Andersen & Co. Ryan received a BA from Stanford University. |
 W. BRADFORD GARYVice President, Government Operations Allergan Mr. Gary served on the staff of former U.S. Rep. Les Aspin (D-WI; 1971-1993). He also served as United States Senate staff. In government service, Mr. Gary was a professional staff member specializing in national security matters. Prior to his appointment with Allergan in 1991, he was a senior executive with 3M Company, Anheuser-Busch Companies, Baxter International, and the Warner-Lambert Company. Mr. Gary graduated from George Washington University and was a Congressional Fellow in the university’s Political Science Department. He did additional graduate work at George Washington and at Cambridge University in the United Kingdom. |
 KENNETH G. HAYES, JR.President & CEO Biomerix Corporation Ken Hayes joined Biomerix Corporation in 2008 as President, Chief Executive Officer, and Director. Ken has over 30 years experience in Fortune 500 and ventured-funded medical device companies. His career has focused on identifying new medical technologies, developing safe and effective therapies, collaborating with physician thought leaders, and recruiting passionate teams to build significant markets and successful companies. Ken was President, CEO and a Director with Radiant Medical, a venture-backed, clinical-stage medical technology company with a state-of-the-art endovascular therapeutic hypothermia system used for a variety of cardiovascular, neurological and renal indications. Ken sold Radiant Medical to ZOLL Medical Corporation in late 2007. From 1997 to 1999, Ken served on the Global Management Board of Sofamor Danek Group, the global leader in spinal and cranial products and was President of Surgical Navigation Technologies, the worldwide leader of computer-assisted surgery systems used in the treatment of cranial, spinal, sinus, and orthopedic disorders. Ken graduated with a Bachelor of Science degree in Business Administration & Marketing with honors from Marist College in 1974. Ken also serves on the Boards of Invuity, a private medical device company and the Medical Device Manufacturers Association (MDMA). |
 ROBERT S. KIEVALFounder & Chief Technology Officer CVRx, Inc. Robert Kieval is Founder, Executive Vice President and Chief Technology Officer of CVRx, Inc., a private medical device company located in Minneapolis, MN. He is a member of its Board of Directors, and served as President and CEO of CVRx from its inception in 2001 through October, 2006. During that time, he advanced the company from initial product concept through FDA approval to commence a pivotal clinical trial of CVRx’s flagship product, the Rheos Baroreflex Hypertension Therapy System. In 2006, Dr. Kieval was named an Innovator of the Year by Twin Cities Finance & Commerce. Kieval has over 16 years of medical device industry experience. His previous positions include Business Development Director at ProtoStar, Inc., and divisional Medical Director at Medtronic, Inc. He completed his undergraduate and graduate training at The University of Pennsylvania, where he received doctorate degrees in Veterinary Medicine and in Physiology. In addition to serving as a Director of CVRx, Kieval also currently serves on the Board of the Medical Device Manufacturers Association. |
 J. CASEY MCGLYNNPartner & Chairman, Life Sciences Group Wilson Sonsini Goodrich & Rosati J. Casey McGlynn joined Wilson Sonsini Goodrich & Rosati in 1978 and formed the Life Sciences Group at the firm in 1990. It is a nationally recognized leader in the representation of startup and emerging growth companies in the life sciences field. Mr. McGlynn has one of the largest practices in the country focused on Medical Devices. Mr. McGlynn has formed, sold and taken public many of the most important medical device companies started during the last 25 years. He has extensive hands on experience in helping entrepreneurs form, build, fund and sell their companies. Mr. McGlynn has helped to form and participated with the boards of companies in all of the major Medical Device fields, including biologics, cancer, cardiovascular, cardiac surgery, congestive heart failure, cosmetic medicine, diagnostics, electrophysiology, ENT, gastroenterology, general surgery, hearing, imaging, monitoring, neurosurgery, obesity, ophthalmology, orthopedics, peripheral vascular disease, renal therapy, sports medicine, urology, and women's health. Over the last 30 years he has built close working relationships with an unparalleled list of entrepreneurs, doctors, investors, engineers, and managers in this industry. Through his portfolio of companies he has met with and negotiated with the leaders of all of the major Medtech acquirers. |
 GUY NOHRAPartner Alta Partners Guy Nohra is a co-founder of Alta Partners, and was also a partner at Burr, Egan, Deleage & Co., which he joined in 1989. Guy has been involved in the funding and development of notable medical technology and life science companies including Cutera, Innerdyne, R2 Technology, deCODE genetics, and Vesica. Previously, Guy was Product Manager of Medical Products with Security Pacific Trading Corporation. He was responsible for a multi-million dollar product line and traveled extensively in Korea, Taiwan, Hong Kong, China and Southeast Asia. Currently, Guy serves on the board of directors of several private companies, including AcelRx, ATS Medical, Carbylan Biosurgery, Coapt Systems, Paracor Medical, PneumRx and Vertiflex, and is the Chairman of the Board of USGI Medical. He also serves on the board of directors of the Medical Device Manufacturing Association (MDMA). He was named to the 2007 Forbes "Midas List" of dealmakers in high-tech and life sciences. He holds a Master of Business Administration from the University of Chicago and a Bachelor of Arts in History from Stanford University. |
 HOWARD ROOTChief Executive Officer Vascular Solutions Howard Root is the Chief Executive Officer of Vascular Solutions, Inc., a medical device company he co-founded in 1997, took public in July 2000 and has led since inception. Over the last five years Vascular Solutions has developed and launched over 30 new devices for the diagnosis and treatment of vascular conditions, resulting in over $50 million in annual sales and profitability. Previously, Mr. Root was Vice President of ATS Medical, Inc. and practiced corporate law at the law firm of Dorsey & Whitney. |
 MARK M. SIECZKAREKPresident & CEO Conceptus, Inc. Mark Sieczkarek joined Conceptus in 2003 as President, Chief Executive Officer, and as a member of the company’s Board of Directors. Prior to joining, he was President of the Americas for Bausch and Lomb, Inc., a full service ophthalmology company with eyecare products ranging from laser refractive surgery, contact lenses and pharmaceuticals, to consumer eyecare products. He originally joined the company in 1995 and served as Corporate Vice President from 1999 to 2001 and as President of both their European and American operations. Sieczkarek held executive level finance positions with Bristol-Myers-Squibb subsidiaries and Sanofi Diagnostics Pasteur from 1980 to 1993. Sieczkarek has Bachelor’s degree in Accounting from the State University of New York at Buffalo and a Master’s degree in Business Administration from Canisius College. Sieczkarek also serves on the Boards of Thermage, Inc., public company in the aesthetics industry, the Medical Device Manufacturers Association (MDMA), and is a Trustee on the Board of St. John Fisher College. |
 JO ELLEN SLURZBERGVice-President Reimbursement and Health Policy Guided Delivery Systems Ms. Slurzberg joined Guided Delivery Systems, Inc. in October 2008, a private medical device start up, as Vice President, Health Policy and Strategic Planning. She is responsible for worldwide strategic reimbursement and health policy. Prior to GDS, she worked for Almyra, Inc., a private international medical device holding company as Vice-President of Reimbursement. From 2000-2004, Ms. Slurzberg was part of the executive consulting team at Boston Healthcare Associates, serving as Vice-President of Consulting, leading the strategic reimbursement practice, consulting to the medical device, in vitro diagnostics, pharmaceutical, and biotechnology industry, as well as to various investment banks and venture capital firms. She has over 25 years of experience in the life sciences industry, with a focus on US and EU reimbursement. In 2006, Ms. Slurzberg was elected to serve on the Board of Directors of the Medical Device Manufacturers Association (MDMA) and she chairs the MDMA Reimbursement Working Group. In 2005, MX magazine (Canon Communications) profiled her among four US reimbursement experts for the year and in 2006 was named to the MX Advisory Board. She has conducted training programs and authored publications on general reimbursement, including two Harvard Business School Notes with Professor Regina Herzlinger. She speaks frequently on reimbursement related business planning and development topics. |
 THOMAS THOMPSONPresident Neuro Resource Group, Inc. Tommy Thompson is a successful and recognized leader in the medical device industry. His 30 years as a President and CEO has included 5 years as a Division President for Baxter Healthcare, and 18 years with Quest Medical (now Advanced Neuromodulation Systems, Inc.) of which he was a founder. Thompson brings to NRG a wealth of experience that has included private funding, strategic alliances and three public offerings. Thompson has co-founded two companies that manufactured products for intravenous drug delivery, cardiovascular surgery, and implantable neurostimulation. In the US, Thompson was co-founder and founding chairman of the Medical Device Manufacturing Association, which played a key role in the legislative reform of the FDA in 1997 and the reform of Group Purchasing Organization practices in 2002. With his roots in electronic engineering, Thompson has also been responsible for major development programs in microprocessor-based instrumentation and sterile, disposable medical devices. Thompson received his B.S.E.E. from the University of Texas. |
 PAUL TOUHEYPresident & CEO Fujirebio Diagnostics, Inc. As President and CEO of Fujirebio Diagnostics, Inc. (FDI), Paul Touhey leads the world’s premier cancer diagnostics companies. Touhey brings more than 25 years of industry experience to the position, in which he is responsible for the company’s growth in the competitive in vitro diagnostics industry. Touhey joined FDI, formerly Centocor Diagnostics, in 1985, where he has held a variety of positions including Senior Vice President of Operations. Prior to FDI and Centocor, Touhey worked for Johnson & Johnson in a variety of positions with increasing levels of responsibility and management. Touhey is past Chairman and current member of the Board of the Medical Device Manufacturers Association (MDMA), a national trade association representing the entrepreneurial sector of the medical device industry in the United States, and is a member of the FDA/Industry Grass Roots Task Force and the Board of the Pennsylvania Bio Association. Touhey established the Companies of Caring Campaign with the Community Volunteers in Medicine, a Chester County charity focusing on providing medical care to the uninsured. Touhey serves on the Board of Directors of Orthovita, Inc., a publicly traded biomaterials company. Touhey received his Bachelor of Arts degree in Political Science from Temple University. |
 C. RUSSELL TRENARY, IIIExecutive Vice President, Global Public Policy & Medical Education Advanced Medical Optics, Inc. C. Russell Trenary III (Russ) is Executive Vice President, Global Public Policy and Medical Education. He rejoined AMO after the company’s 2002 spin-off from Allergan. From 1996 to 2001, Mr.Trenary was the President of Sunrise Technologies International, Inc., and from 1997 to 2001 he held the additional title of Chief Executive Officer. From 1995 to 1996, Mr. Trenary was Senior Vice President, Worldwide Sales and Marketing, for Vidamed, Inc. Mr. Trenary began his career in 1981 with American Hospital Supply Corporation (AHSC), and in 1986, was a manager for the American Medical Optics division of AHSC when that division was acquired by Allergan. This became the business under which Allergan entered the ophthalmic surgical market. While at Allergan from 1987 to 1995, Mr.Trenary held positions of increasing responsibility in the surgical business segment, culminating with the position of Senior Vice President and General Manager of AMO Surgical Products, a position he held from 1991 to 1995. Mr. Trenary holds a Master of Business Administration from Michigan State University and a Bachelor of Science in Business Administration from Miami University (Ohio). He is an active member on the Board of Directors for the Medical Device Manufacturers Association, Prevent Blindness America, Pan-American Ophthalmological Foundation and the American Optometric Foundation. |
 MARK WANPartner Three Arch Partners Mark is a founding partner of Three Arch Partners. Prior to cofounding Three Arch Partners, Mark was a general partner at Brentwood Associates. Since starting in venture capital in 1987, Mark has emphasized working with entrepreneurs in very early stage companies. He has often assumed temporary operating responsibility, managing key functions during a company’s young life. He has served on the boards of many private and public medical companies including Biopsys Medical, Odyssey Healthcare and Perclose. Mark holds a B.S. in Engineering and a B.A. in Economics from Yale University. He also holds an M.B.A. from the Stanford Graduate School of Business. |
| Board Member Emeritus |
 RONALD B. EARLE As past Group Senior Vice President, B. Braun OEM Division, B. Braun Medical, Inc., a corporate position reporting to Main office in Germany, Earle was responsible for the development of a global strategic operation, utilizing the full resources of the B. Braun organization around the world. The position responsibilities include overseeing the OEM/Industrial Division and International Division, plus the establishment of a global team dedicated to the OEM/Contract manufacturing business. Under his guidance since 1982, OEM operations grew almost 15-fold to over $200 million in revenue. Recently, Earle was named one of the nation’s most notable 100 medical device executives by Medical Device & Diagnostic Industry. He has served on the Board of Directors for the Medical Device Manufacturers Association since 2001, and sits on the Board of Visitors to the School of Pharmacy, Temple University, and is a member of the Medical Products Outsourcing advisory board. Earle has written several articles for various industrial publications on outsourcing trends and new technologies in the pharmaceutical and medical device industries. |